Evaxion Biotech Pseudomonas Aeruginosa Vaccine Patent

The USPTO granted patent US12606597B2 to Evaxion Biotech A/S covering immunogenic proteins from Pseudomonas aeruginosa, along with associated nucleic acids, vectors, transformed cells for protein expression, and methods for prophylaxis of infection using those materials. This is a standard patent grant conferring intellectual property protection on the assignee.

Competitors developing vaccines or immunogenic products targeting Pseudomonas aeruginosa should review this patent for freedom-to-operate considerations, as the granted claims may cover prophylactic methods and compositions within the patent's scope.